ChromaDex Corporation (CDXC)
ChromaDex Statistics
Share Statistics
ChromaDex has 76.38M shares outstanding. The number of shares has increased by 1.43% in one year.
Shares Outstanding | 76.38M |
Shares Change (YoY) | 1.43% |
Shares Change (QoQ) | 0.59% |
Owned by Institutions (%) | 23.2% |
Shares Floating | 48.36M |
Failed to Deliver (FTD) Shares | 8 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.99M, so 2.61% of the outstanding shares have been sold short.
Short Interest | 1.99M |
Short % of Shares Out | 2.61% |
Short % of Float | 4.12% |
Short Ratio (days to cover) | 4.11 |
Valuation Ratios
The PE ratio is -21.71 and the forward PE ratio is 44.15. ChromaDex's PEG ratio is 0.32.
PE Ratio | -21.71 |
Forward PE | 44.15 |
PS Ratio | 1.28 |
Forward PS | 3.1 |
PB Ratio | 3.77 |
P/FCF Ratio | 15.39 |
PEG Ratio | 0.32 |
Enterprise Valuation
ChromaDex Corporation has an Enterprise Value (EV) of 83.18M.
EV / Earnings | -16.84 |
EV / Sales | 1 |
EV / EBITDA | -21.36 |
EV / EBIT | -14.86 |
EV / FCF | 11.94 |
Financial Position
The company has a current ratio of 2.4, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.4 |
Quick Ratio | 1.7 |
Debt / Equity | 0.12 |
Total Debt / Capitalization | 10.33 |
Cash Flow / Debt | 2.17 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.17% and return on capital (ROIC) is -17.64%.
Return on Equity (ROE) | -0.17% |
Return on Assets (ROA) | -0.09% |
Return on Capital (ROIC) | -17.64% |
Revenue Per Employee | $788,396.23 |
Profits Per Employee | $-46,584.91 |
Employee Count | 106 |
Asset Turnover | 1.52 |
Inventory Turnover | 2.26 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 231.93% in the last 52 weeks. The beta is 2.21, so ChromaDex's price volatility has been higher than the market average.
Beta | 2.21 |
52-Week Price Change | 231.93% |
50-Day Moving Average | 5.62 |
200-Day Moving Average | 4.36 |
Relative Strength Index (RSI) | 46.12 |
Average Volume (20 Days) | 443.56K |
Income Statement
In the last 12 months, ChromaDex had revenue of 83.57M and earned -4.94M in profits. Earnings per share was -0.07.
Revenue | 83.57M |
Gross Profit | 50.78M |
Operating Income | -5.6M |
Net Income | -4.94M |
EBITDA | -3.89M |
EBIT | -5.6M |
Earnings Per Share (EPS) | -0.07 |
Balance Sheet
The company has 27.17M in cash and 3.28M in debt, giving a net cash position of 23.9M.
Cash & Cash Equivalents | 27.17M |
Total Debt | 3.28M |
Net Cash | 23.9M |
Retained Earnings | -190.46M |
Total Assets | 56.52M |
Working Capital | 34.44M |
Cash Flow
In the last 12 months, operating cash flow was 7.12M and capital expenditures -148K, giving a free cash flow of 6.97M.
Operating Cash Flow | 7.12M |
Capital Expenditures | -148K |
Free Cash Flow | 6.97M |
FCF Per Share | 0.09 |
Margins
Gross margin is 60.76%, with operating and profit margins of -6.7% and -5.91%.
Gross Margin | 60.76% |
Operating Margin | -6.7% |
Pretax Margin | -5.91% |
Profit Margin | -5.91% |
EBITDA Margin | -4.66% |
EBIT Margin | -6.7% |
FCF Margin | 8.34% |
Dividends & Yields
CDXC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1.27% |
FCF Yield | 1.65% |
Analyst Forecast
The average price target for CDXC is $8, which is 45.2% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8 |
Price Target Difference | 45.2% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Stock Splits
The last stock split was on Apr 13, 2016. It was a backward split with a ratio of 1:3.
Last Split Date | Apr 13, 2016 |
Split Type | backward |
Split Ratio | 1:3 |
Scores
Altman Z-Score | 9.79 |
Piotroski F-Score | 6 |